Pro. Mingfang Zhao, MD, is currently the director of Second Ward of Medical Oncology, The First Hospital of China Medical University. She mainly engaged in the precise diagnosis and treatment and clinical translational research of a variety of solid tumors, especially good at the diagnosis and treatment of lung cancer and translational research. She has served as PI for several multi-center Phase III clinical trials and participated as the important contributor for many regional clinical trials as well. Dr. Mingfang Zhao has authored or co-authored in multiple medical articles on lung cancer and other malignancies. She is now the member of Lung cancer Group of the Oncology Branch of Chinese Medical Association; member of Chinese Society of Clinical Oncology (CSCO) Non-small Lung Cancer Professional Committee; director of Guangdong Clinical Trial Association (CTONG); member of the Lung Cancer Professional Committee and Member of the Internal Medicine Group of China Anti-cancer Association.